Discontinued — last reported Q3 '25
Natera, Inc. Product — Increase Decrease Revenues increased by 6.5% to -$2.90M in Q3 2025 compared to the prior quarter. Year-over-year, this metric declined by 514.3%, from $700.00K to -$2.90M. This is a positive signal — higher values indicate stronger performance for this metric.
An increase signals strong market penetration and product demand, whereas a decrease may indicate market saturation or competitive pressure.
This metric measures the year-over-year or period-over-period variance in total revenue generated from the product segme...
Comparable to segment revenue growth rates reported by other life sciences and diagnostic technology companies.
ntra_segment_product_increase_decrease_revenues| Q2 '22 | Q3 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q2 '25 | Q3 '25 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $1.10M | $1.60M | $5.70M | $800.00K | $1.20M | $2.10M | $1.70M | $700.00K | $6.00M | -$3.10M | -$2.90M |
| QoQ Change | — | +45.5% | +256.3% | -86.0% | +50.0% | +75.0% | -19.0% | -58.8% | +757.1% | -151.7% | +6.5% |
| YoY Change | — | — | — | -27.3% | -25.0% | -63.2% | +112.5% | -41.7% | — | -282.4% | -514.3% |